Log in

Start Your Membership Now

Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in
About
Contact
Partnership

Become A Member
Log in

Markets
Services
Customers

Market Intel Homepage

Search Library

Publications
Markets
Topics
Executive Institutes
Professional Development Programs
The OPEN MINDS Leadership & Management Certificate The OPEN MINDS CFO Consortium
Tools
Assessments
View By Topic View By Partner

Health Plan Trends

Population Health

Successfully Managing Through Uncertain Times Series

The OPEN MINDS CFO Consortium

The OPEN MINDS Leadership & Management Certificate

Alera Health

ContinuumCloud

Otsuka

View By Topic View By Partner

Adaptive AI In Practice

AI In Process/Workflow Improvement

Building Managed LTSS Networks

Crisis Management & Technology

Hybrid/Virtual Care

Innovations In Housing

Long-Term Services & Supports

Navigating Medicaid

Performance Management

Technology Strategy

Trauma Informed Approaches

AI/Advanced Technologies To Improve Outcomes

AI Powered Documentation & Compliance

CCBHCs

Data-Driven Care Optimization

Innovation

Integrated Insurance: Risk & Benefits

Medication-Assisted Treatment

Operational Efficiency & Funding In Addiction Services

Smart Living Tools

Transformational Leadership For Non-Profits

Whole Person Care

AI in Analytics

Automation Of Services/Processes

Clinically Integrated Systems Of Care

EHR-Driven Care Transformation

Innovations In Autism & Behavioral Healthcare

IT Operational Efficiency

Metrics-Based Mgmt//Data-Driven Decision Making

Operational Excellence

Tech-Enabled Service Delivery

Transforming Data To Action

Workforce Optimization

ContinuumCloud

Netsmart

Cantata Health Solutions

Clinically AI

Five Points Technology Group

Grafton Integrated Health Network

iCareManager

Juno Health

NextGen Healthcare

ServiceWorks

The BI Collaborative

Core Solutions

5e Analytics

Carelon

Eleos

Genoa Healthcare

GrandCare Systems

Independent Living Systems

Medicus IT

Radicle Health

ShiftAbility

Vista Care

Qualifacts

Altruix

CCNY

FEI Systems

Goodlife Innovations

Hartman Executive Advisors

Johnson, Kendall, & Johnson

Mend

Relias

Streamline Healthcare Solutions

Vivant Behavioral Healthcare

Weekly News Wire | November 21, 2025

Survey:12% Of Adults Take A GLP-1 Medication For Diabetes, Obesity, Other Condition

Twelve percent of 1,350 U.S. adults who responded to the 2025 KFF Health Tracker Poll said they were currently taking a GLP-1 medication as treatment for diabetes, obesity, or for other approved uses, such as cardiovascular disease and sleep apnea.

Brand names for this class of medications with indications for diabetes include Ozempic, Mounjaro, Rybelsus, and Trulicity. Brand names for GLP-1 medications to treat obesity include Wegovy and Zepbound. Among those taking a GLP-1 medication, use was highest among adults who reported being diagnosed with conditions the medications are approved to treat.

Diabetes: reported by . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: